Active

Veeda Clinical Research Limited

Veeda Clinical Research Limited IPO Details

Listing Date

-

Bid Price

₹0 - ₹0

Lot Size

0 Shares

Minimum Investment

Issue Size

₹0 Cr

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

-

tick

Offer End Date

-

tick

Allotment Date

-

tick

Refund Initiation

-

tick

Demat Transfer

-

tick

Listing Date

-

Veeda Clinical Research Limited Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 0% 0%
Public Group 100% 100%

Veeda Clinical Research Limited IPO Reservation

QIB Shares Offered 0 (0%)
NII (HNI) Shares Offered 0 (0%)
Retail Shares Offered 0 (0%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Veeda Clinical Research Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) [-] [-] ₹[-]
Retail (Max) [-] [-] ₹[-]
S HNI (Min) [-] [-] ₹[-]
S HNI (Max) [-] [-] ₹[-]
B HNI (MIN) [-] [-] ₹[-]

Veeda Clinical Research Limited IPO registrar

MUFG Intime India Pvt Ltd
Phone Number + 91 81081 14949
Email Id Veedalifesciences.ipo@linkintime.co.in
Website https://in.mpms.mufg.com

Veeda Clinical Research Limited IPO Lead Manager

1. Axis Capital Ltd

2. CLSA India Pvt ltd

3. IIFL Capital Services Ltd

4. SBI Capital Markets Ltd

Veeda Clinical Research Limited Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹855.76 Cr ₹1,059.97 Cr ₹457.16 Cr
Reserves and Surplus ₹842.6 Cr ₹1,047.37 Cr ₹446.58 Cr
Total Borrowing ₹405.97 Cr ₹261.68 Cr ₹48.57 Cr

Veeda Clinical Research Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 0 0 0
Non Institutional Investors (NIIs) 0 0 0
Retail Individual Investors (RIIs) 0 0 0
Total 0 0 0

Strength of Veeda Clinical Research Limited

  • A platform for drug development needs of customers.
  • Successful integration of growth opportunities through acquisitions.
  • Strong scientific capabilities across business services.
  • Established quality credentials with a strong focus on quality control management.
  • Global and diverse management team with deep scientific expertise.

Risks Involved

  • The company derives a significant portion of its revenue from contracts with the company top clients. Its top five clients contributed more than 41.16% of the company revenue from contract with customers in the six months period ended September 30, 2024 with its top client that contributed approximately 28.37% of the company revenue from contract with customers in the six months period ended September 30, 2024. Loss of any of these clients could adversely affect its business, results of operations, cash flows and financial condition.
  • The potential loss or delay under any of its large contracts or of multiple key client contracts could adversely affect the company financial results specifically since the relationship of backlog to revenues varies over time and may not be fully realisable in the event of contract cancellation.
  • The company required to perform its services in accordance with contractual requirements, regulatory standards in applicable jurisdictions and ethical considerations. Any adverse action by any authority, including the Food and Drug Administration or the European Medicines Agency against it would negatively impact on the company ability to offer its services to the company clients and adversely impact its business and prospects.
  • If the company fails to deliver services in accordance with contractual requirements, the company could be subject to significant costs or liability and its reputation could be harmed.
  • The company has incurred losses for the six months period ended September 30, 2024 and Financial Year 2024 and may continue to do so in the future, which may adversely impact its business and the value of the Equity Shares.
  • The company financial performance is dependent on the company ability to secure business from clients in the pharmaceutical and biopharmaceutical industry. Consequently, any adverse changes in outsourcing trends in the pharmaceutical and biopharmaceutical industry and changes in aggregate spending and research and development budgets could adversely affect its operating results and growth rate.
  • The company studies and clinical trials could subject it to potential liability that may adversely affect its business, results of operations, cash flows and financial condition.
  • The company may not derives the anticipated benefits from its strategic investments and acquisitions, including the company acquisition of Heads and its may not be successful in pursuing future investments and acquisitions.
  • Failures to maintain confidential information of the company clients could adversely affect its business, results of operations, cash flows and financial condition and/or reputation.
  • The company is subject to risks arising from interest rate which could adversely affect its business, results of operations, cash flows and financial condition.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Striders Impex Limited IPO
Bidding Period
26th Feb 2026 - 3rd Mar 2026
Price Range
₹71.0 - 72.0
IPO Size
₹36,29,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹75.0 - 79.0
IPO Size
₹1,65,00,00,000
MANILAM INDUSTRIES INDIA LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹65.0 - 69.0
IPO Size
₹40,00,00,000
FRACTAL INDUSTRIES LIMITED IPO
Bidding Period
16th Feb 2026 - 2nd Feb 2026
Price Range
₹205.0 - 216.0
IPO Size
₹49,00,00,000
MARUSHIKA TECHNOLOGY LIMITED IPO
Bidding Period
12th Feb 2026 - 2nd Feb 2026
Price Range
₹111.0 - 117.0
IPO Size
₹27,00,00,000
FRACTAL ANALYTICS LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹857.0 - 900.0
IPO Size
₹28,34,00,00,000
AYE FINANCE LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹122.0 - 129.0
IPO Size
₹10,10,00,00,000
BIOPOL CHEMICALS LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹102.0 - 108.0
IPO Size
₹31,00,00,000
PAN HR SOLUTION LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹74.0 - 78.0
IPO Size
₹17,00,00,000
NFP SAMPOORNA FOODS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
BRANDMAN RETAIL LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹167.0 - 176.0
IPO Size
₹86,00,00,000
GROVER JEWELLS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹83.0 - 88.0
IPO Size
₹34,00,00,000
C K K RETAIL MART LIMITED IPO
Bidding Period
30th Jan 2026 - 2nd Feb 2026
Price Range
₹155.0 - 163.0
IPO Size
₹88,00,00,000
ACCRETION NUTRAVEDA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹122.0 - 129.0
IPO Size
₹25,00,00,000
MSAFE EQUIPMENTS LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹116.0 - 123.0
IPO Size
₹66,00,00,000
KANISHK ALUMINIUM INDIA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹73.0 - 73.0
IPO Size
₹29,00,00,000
KASTURI METAL COMPOSITE LIMITED IPO
Bidding Period
27th Jan 2026 - 1st Jan 2026
Price Range
₹61.0 - 64.0
IPO Size
₹18,00,00,000
HANNAH JOSEPH HOSPITAL LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹67.0 - 70.0
IPO Size
₹42,00,00,000
SHAYONA ENGINEERING LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹140.0 - 144.0
IPO Size
₹15,00,00,000
KRM AYURVEDA LIMITED IPO
Bidding Period
21st Jan 2026 - 1st Jan 2026
Price Range
₹128.0 - 135.0
IPO Size
₹77,00,00,000
SHADOWFAX TECHNOLOGIES LIMITED IPO
Bidding Period
20th Jan 2026 - 1st Jan 2026
Price Range
₹118.0 - 124.0
IPO Size
₹19,07,00,00,000
  • All
  • MainBoard
  • SME
MARUSHIKA TECHNOLOGY LIMITED IPO
Issue Prize
117.00
Listing Day Close
114.00(-2.56%)
FRACTAL ANALYTICS LIMITED IPO
Issue Prize
900.00
Listing Day Close
847.40(-5.89%)
AYE FINANCE LIMITED IPO
Issue Prize
129.00
Listing Day Close
128.90(0.00%)
BIOPOL CHEMICALS LIMITED IPO
Issue Prize
108.00
Listing Day Close
105.50(-1.85%)
PAN HR SOLUTION LIMITED IPO
Issue Prize
78.00
Listing Day Close
78.01(0.00%)
BRANDMAN RETAIL LIMITED IPO
Issue Prize
176.00
Listing Day Close
192.15(9.09%)
GROVER JEWELLS LIMITED IPO
Issue Prize
88.00
Listing Day Close
100.80(14.77%)
C K K RETAIL MART LIMITED IPO
Issue Prize
163.00
Listing Day Close
171.15(4.91%)
ACCRETION NUTRAVEDA LIMITED IPO
Issue Prize
129.00
Listing Day Close
191.20(48.06%)
MSAFE EQUIPMENTS LIMITED IPO
Issue Prize
123.00
Listing Day Close
150.30(21.95%)
KANISHK ALUMINIUM INDIA LIMITED IPO
Issue Prize
73.00
Listing Day Close
55.48(-24.66%)
KASTURI METAL COMPOSITE LIMITED IPO
Issue Prize
64.00
Listing Day Close
63.16(-1.56%)
HANNAH JOSEPH HOSPITAL LIMITED IPO
Issue Prize
70.00
Listing Day Close
68.25(-2.86%)
SHAYONA ENGINEERING LIMITED IPO
Issue Prize
144.00
Listing Day Close
151.00(4.86%)
KRM AYURVEDA LIMITED IPO
Issue Prize
135.00
Listing Day Close
180.70(34.07%)
SHADOWFAX TECHNOLOGIES LIMITED IPO
Issue Prize
124.00
Listing Day Close
109.90(-11.29%)
DIGILOGIC SYSTEMS LIMITED IPO
Issue Prize
104.00
Listing Day Close
79.05(-24.04%)
ARITAS VINYL LIMITED IPO
Issue Prize
47.00
Listing Day Close
44.65(-4.26%)
ARMOUR SECURITY INDIA LIMITED IPO
Issue Prize
57.00
Listing Day Close
43.35(-24.56%)
AM
AMAGI MEDIA LABS LIMITED IPO
Issue Prize
361.00
Listing Day Close
348.00(-3.60%)

Frequently Asked Questions

What is Veeda Clinical Research Limited IPO?

Answer Field

Veeda Clinical Research Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on .

When Veeda Clinical Research Limited IPO will open?

Answer Field

The Veeda Clinical Research Limited IPO opens on [-] and closes on [-].

What is the lot size of Veeda Clinical Research Limited?

Answer Field

Veeda Clinical Research Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Veeda Clinical Research Limited IPO?

Answer Field

You can apply in Veeda Clinical Research Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Veeda Clinical Research Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Veeda Clinical Research Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Veeda Clinical Research Limited IPO listing date?

Answer Field

The Veeda Clinical Research Limited listing date is [-].

Who is the registrar of Veeda Clinical Research Limited IPO?

Answer Field

The registrar of Veeda Clinical Research Limited IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Axis Capital Ltd,CLSA India Pvt ltd,IIFL Capital Services Ltd,SBI Capital Markets Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Veeda Clinical Research Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Veeda Clinical Research Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Veeda Clinical Research Limited IPO?

Answer Field

To apply for Veeda Clinical Research Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Veeda Clinical Research Limited?

Answer Field

The price of each Veeda Clinical Research Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Veeda Clinical Research Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|